Randomized phase II trial on primary chemotherapy (CHT) with high-dose methotrexate (MTX) alone or associated with high-dose cytarabine (ARAC) for patients (PTS) with primary CNS lymphoma (PCNSL)

Ferreri AJ;Foppoli M;Martelli M;Pangalis G;Frezzato M;Cabras G;Fabbri A;Corazzelli G;Ilariucci F;Rossi G;Soffietti R;Stelitano C;Vallisa D;Zaja F;Zoppegno L;Aondio G;Annibali O;Balzarotti M;Brandes A;Fajardo J;Gomez H;Guarini A;Pinotti G;Rigacci L;Uhlmann C;PONZONI , MAURILIO;Reni M;Zucca E;Cavalli F.

2008-01-01